Jobs at Intellia Therapeutics

The Director of Commercial FP&A will develop revenue models, lead financial planning for commercial operations, and establish GTN frameworks for a biotech launch.

Oversee a team applying genomic tools for gene editing therapies, managing projects, budgets, and collaborations to ensure innovative advancements.

The Associate Director Data Architect is responsible for managing enterprise integrations, establishing standards, driving automation, and ensuring secure, scalable connectivity across IT systems.

Manage administration, support, enhancement, and optimization of Veeva commercial and medical platforms. Act as liaison between business, IT, and vendors; translate requirements into technical solutions; lead UAT, impact assessments, process improvements, documentation, and compliance alignment (FDA/HIPAA). Provide technical leadership and oversee incident resolution and integrations.

Field commercial leader responsible for launching an in vivo CRISPR therapy across WA, OR, and AK. Develop territory plans, build KOL relationships, present Phase III clinical data, manage complex treatment pathways, coordinate hub and reimbursement support, and collaborate cross-functionally to drive patient access and uptake in a rare disease market.

Lead commercial launch and territory strategy for an in vivo CRISPR therapy across five Midwestern states. Build relationships with immunologists, allergists, emergency physicians, and HAE centers; present Phase III clinical data; educate on CRISPR mechanism and patient pathways; manage complex sales cycles, hub integration, and payer alignment; collaborate with Medical Affairs and Market Access to drive treatment access and adoption.

Lead the commercial launch of an in vivo CRISPR therapy across Detroit and Grand Rapids. Develop territory plans, prioritize accounts, build KOL relationships, educate providers on CRISPR MOA and Phase III data, manage complex treatment pathways and hub integration, coordinate with Medical Affairs and Market Access, and drive adoption through pipeline management and competitive differentiation.

Lead commercial launch of an in vivo CRISPR therapy across Florida and Puerto Rico. Develop territory plans, build KOL relationships, present clinical data, educate providers on CRISPR and HAE management, manage complex treatment pathways and hub integration, coordinate with Medical Affairs and Market Access, and drive patient access and uptake through strategic account development and competitive differentiation.

Lead commercial launch and territory commercialization for an in vivo CRISPR therapy across Pennsylvania and West Virginia. Develop territory plans, build KOL and account relationships, present clinical data, educate providers on CRISPR MOA, coordinate patient access and hub services, gather competitive intelligence, and collaborate with Medical Affairs and Market Access to drive patient treatments and coverage.

Lead commercial launch and territory commercialization of a first-in-class in vivo CRISPR therapy for HAE across Northern California. Develop territory plans, build KOL relationships, present clinical data, manage complex treatment pathways and hub integration, collaborate with Medical Affairs and Market Access, and drive account activation and patient access.

Lead commercial launch of an in vivo CRISPR therapy for HAE in the Denver territory. Build territory plans, develop key account relationships, present Phase III data, educate providers on CRISPR MOA, manage complex treatment pathways, coordinate hub and cross-functional teams, and drive uptake through competitive differentiation and reimbursement alignment.

Lead commercial launch and territory management for an in vivo CRISPR therapy for HAE in Long Island. Develop territory plans, build KOL and account relationships, present clinical data, educate on CRISPR MOA, manage complex treatment pathways and hub integration, coordinate cross-functionally (Medical Affairs, Market Access), and drive adoption through strategic account and launch execution.

Lead commercial launch and territory commercialization for an in vivo CRISPR HAE therapy across North Florida. Develop territory plans, build KOL and institutional relationships, present Phase III clinical data, educate providers on CRISPR MOA, manage complex treatment and patient pathways, coordinate hub services and cross-functional teams, and execute competitive and access strategies to drive patient treatments.

Lead commercial launch of an in vivo CRISPR therapy for HAE in the Los Angeles territory. Develop territory and account plans, build KOL relationships, present clinical data, educate providers on CRISPR and disease management, coordinate patient access/hub services, gather competitive intelligence, and work cross-functionally with medical affairs and market access to drive patient treatment completion.

Lead commercial launch of a first-in-class in vivo CRISPR therapy for HAE across a multi-state territory. Build KOL relationships, educate clinicians on MOA and Phase III data, manage complex treatment pathways, coordinate hub and payer processes, develop territory/account plans, and drive product adoption through cross-functional collaboration and competitive differentiation.

Lead the commercial launch of an in vivo CRISPR therapy for HAE in the Cleveland territory. Build and prioritize accounts, educate clinicians on CRISPR MOA and Phase III data, manage complex patient pathways and hub integration, coordinate with Medical Affairs and Market Access, and drive uptake through strategic relationships and competitive differentiation.

Lead commercial launch of an in vivo CRISPR therapy across AZ, NM, and TX. Develop territory plans, build KOL and account relationships, present clinical data, educate on CRISPR mechanism, manage complex patient/treatment pathways, coordinate hub and cross-functional teams, and drive access and adoption in a competitive rare disease market.

Lead commercial launch of an in vivo CRISPR therapy across California and Hawaii. Develop territory plans, build relationships with immunologists/allergists and HAE centers, present Phase III data, educate on CRISPR MOA, manage complex treatment pathways and hub integration, coordinate cross-functionally with Medical Affairs and Market Access, and execute account strategies to drive patient treatment uptake.

Lead commercial launch of a first-in-class in vivo CRISPR therapy across OK, KS, NE. Develop territory plans, build KOL relationships, present clinical data, manage complex treatment pathways, coordinate hub and cross-functional teams, and drive access and uptake in rare disease settings.

Lead the commercial launch of an in vivo CRISPR therapy for HAE across NY/VT/CT. Build territory plans, prioritize accounts, educate HCPs on CRISPR mechanism and clinical data, manage pipeline and patient journey, coordinate hub services, gather competitive intelligence, and collaborate with Medical Affairs and Market Access to drive treatment adoption and access.